First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, September 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 88 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,429 followers.

PSMA o mostraban una menor acumulación de PSMA después de ciclos previos de terapia. https://t.co/fcP39nJfn6 #FisioHumUCM @FisioHumInnova

08 Nov 2020

Reply Repost Favourite

RT @radiolobt: First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treat…

09 Sep 2019

Reply Repost Favourite

First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer https://t.co/gzd5tCxirz

08 Sep 2019

Reply Repost Favourite